VC-backed Ovid Therapeutics names business development VP
New York-based Ovid Therapeutics Inc, a biopharmaceutical company focused on treating rare and orphan brain diseases, has hired Dr. Anna Kazanchyan as senior vice president of business development. Previously, Dr. Kazanchyan was the founder and managing partner of Primary i-Research LLC. Ovid's backers included Fidelity Management and Research Company, Cowen Private Investments, Sanofi-Genzyme BioVentures, Tekla Capital Management, Sphera Global Healthcare Fund, Jennison Associates (on behalf of certain clients), Redmile Group and Cormorant Asset Management.
15 October 2015•3 mins read
